P
PLX
Protalix Biother
2.440
+0.070+2.95%After Hours: 2.450 +0.010 +0.41%18:23 07/10 EDT
OPEN/PREV CLOSE2.390/2.370
TODAY RANGE2.330-2.450
VOL678.25K
MARKET CAP196.59M
52 WEEK RANGE1.360-3.190
AVG VOL (3M)723.95K
% TURNOVER0.84%
TURNOVER--
P/E (TTM)13.37
% RANGE5.06%
EPS(TTM)0.1825
P/E(FORWARD)12.51
P/B2.924
BVPS0.8344
DIVIDEND--
P/S3.721
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP188.97M
SHARES OUTSTANDING80.57M
NEXT EARNINGS08/12-08/17
FREE FLOAT77.45M
LOT SIZE1
EX-DATE12/20/2019
News
Press Releases
Financial Reports
Profile
TipRanks·06/25 20:48
Protalix Shareholders Approve Directors, Compensation and Incentive Plan
TipRanks·05/21 11:33
Protalix Highlights Elfabrio Dosing Approvals and Growth Plans
TipRanks·05/14 00:15
Protalix Q1 Call: Milestone-Fueled Profit, Bold Targets
Seeking Alpha·05/13 15:52
Protalix reaffirms $78M-$83M 2026 revenue outlook following $25M Elfabrio milestone
Benzinga·05/13 12:19
Transcript: Protalix BioTherapeutics Q1 2026 Earnings Conference Call
Benzinga·05/13 11:11
Earnings Scheduled For May 13, 2026
Seeking Alpha·05/13 10:53
Protalix BioTherapeutics give Q1 results
PR Newswire·05/13 10:50
Protalix BioTherapeutics Reports First Quarter 2026 Financial and Business Results
Seeking Alpha·05/12 22:00
Here are the major earnings before the open Wednesday
Seeking Alpha·05/12 18:07
Protalix BioTherapeutics Q1 Earnings Preview
Seeking Alpha·04/15 18:47
Protalix: Elfabrio Struggles Against Oral Competition
TipRanks·04/02 00:28
Protalix Earnings Call: EU Win, Cash Boost, Trade-Offs
Same Industry
Name/Symbol
Change%
Price